Showing results (261-270 of 300) with videos related to
Sort By:
Pageof 30
Rheumatology (Oxford, England)|June 10, 2022
Use of biologics to treat relapsing and/or refractory polyarteritis nodosa: data from a European collaborative studyJérome Hadjadj, Alice Canzian, Omer Karadag, et al.The Lancet. HIV|June 6, 2022
Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort studyAdam Trickey, Lei Zhang, M John Gill, et al.BMJ Open|February 5, 2026
Doravirine versus dolutegravir-based regimen in antiretroviral treatment-naive people living with HIV-1 (ANRS0392s ELDORADO): protocol for an international, open-label, randomised, non-inferiority, phase III trialAnthony L'hostellier, Charles Kouanfack, Corine Chazallon, et al.Journal of Clinical Medicine|July 9, 2022
Aseptic Abscess Syndrome: Clinical Characteristics, Associated Diseases, and up to 30 Years' Evolution Data on a 71-Patient SeriesLudovic Trefond, Camille Frances, Nathalie Costedoat-Chalumeau, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2021
CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort StudiesFabienne Caby, Marguerite Guiguet, Laurence Weiss, et al.Journal of Viral Hepatitis|June 20, 2023
Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality: A collaboration of cohort studiesAdam Trickey, Suzanne M Ingle, Anders Boyd, et al.Eclinicalmedicine|January 9, 2023
Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019Daniela K van Santen, Rachel Sacks-Davis, Ashleigh Stewart, et al.BMJ Open|November 22, 2024
Booster-free anti-retroviral therapy for persons living with HIV and multidrug resistance (B-Free): protocol for a multicentre, multistage, randomised, controlled, non-inferiority trialMarie Ballif, Dominique Braun, Alexandra Calmy, et al.The Lancet. HIV|January 15, 2024
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studiesRachel Sacks-Davis, Daniela K van Santen, Anders Boyd, et al.Cancers|December 30, 2025
Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort CollaborationAlisa Timiryasova, Lauren Greenberg, Pere Domingo, et al.Pageof 30